The IMPT serves as the ‘communications and information hub’ for the field of multipurpose prevention technologies (MPTs).

Our resource center features a searchable database, providing you access to global MPT research, technical webinars, trainee and career resources, advocacy tools, and more. Search our resources!

Resource Search

Search Results

Giving voice to the end-user: input on multipurpose prevention technologies from the perspectives of young women in Kenya and South Africa

Giving voice to the end-user: input on multipurpose prevention technologies from the perspectives of young women in Kenya and South Africa

Minnis, A.; Krogstad, E.; Shapley-Quinn, M.K.; Agot, K.; Ahmed, K.; & Wagner, L.D. July 2021
Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake

Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake

Lorna Begg, Rebecca Brodsky, Barbara Friedland, Sanyukta Mathur, Jim Sailer, George Creasy Visit Journal Article July 2021
Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe

Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe

Alejandro J. Paredes, Inken K. Ramöller, Peter E., McKenna, Marco T.A. Abbate, Fabiana Volpe-Zanutto, Lalitkumar K.Vora, Maggie Kilbourne-Brook, Courtney Jarrahian, Kurtis Moffatt, Chunyang Zhang, Ismaiel A. Tekko, Ryan F. Donnelly June 2021
Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial

Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial

Joseph A. Politch; Susan Cu-Uvin; Thomas R. Moench; Karen T. Tashima; Jai G. Marathe; Kate M. Guthrie; Howard Cabral; Tara Nyhuis; Miles Brennan; Larry Zeitlin; Hans M. L. Spiegel; Kenneth H. Mayer; Kevin J. Whaley; Deborah J. Anderson February 2021
A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial

A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial

Thomas, M.; Chappell, B.T.; Maximos, B.; Cullwell, K.; & Howard, B. July 2020
Bridging the gap: Advancing multipurpose prevention technologies from the lab into the hands of women

Bridging the gap: Advancing multipurpose prevention technologies from the lab into the hands of women

Young Holt, B., Kiarie, J., Kopf, G., Nanda, K., Hemmerling, A., & Achilles, S. May 2020
Effectiveness of female condom in preventing HIV and sexually transmitted infections: a systematic review protocol

Effectiveness of female condom in preventing HIV and sexually transmitted infections: a systematic review protocol

Effectiveness of female condom in preventing HIV and sexually transmitted infections: a systematic review protocol 07 August 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Condoms Topic(s): Product Introduction / Uptake Reproductive Health Social/Behavioral Context

Mome et al. Visit Journal Article August 2018
Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: A randomised, open-label longitudinal study in Rwandan women

Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: A randomised, open-label longitudinal study in Rwandan women

Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: A randomised, open-label longitudinal study in Rwandan women 23 July 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) MPTs Topic(s): Product Trials Region(s): Africa

Crucitti et al. Visit Journal Article July 2018
Solid state 13C NMR spectroscopy provides direct evidence for reaction between ethinyl estradiol and a silicone elastomer vaginal ring drug delivery system

Solid state 13C NMR spectroscopy provides direct evidence for reaction between ethinyl estradiol and a silicone elastomer vaginal ring drug delivery system

Solid state 13C NMR spectroscopy provides direct evidence for reaction between ethinyl estradiol and a silicone elastomer vaginal ring drug delivery system 14 July 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) MPTs Topic(s): Product Development

McCoy et al. Visit Journal Article July 2018
Technoeconomic modeling of plant-based Griffithsin manufacturing

Technoeconomic modeling of plant-based Griffithsin manufacturing

Technoeconomic modeling of plant-based Griffithsin manufacturing 02 July 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV Product Type(s): Microbicides Topic(s): Product Development Region(s): United States

Alam et al. Visit Journal Article July 2018
Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women 28 June 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) MPTs Topic(s): MPTs Product Trials

Thurman et al. Visit Journal Article June 2018
Development of a vaginal fast-dissolving insert combining Griffithsin and Carrageenan for potential use against sexually transmitted infections

Development of a vaginal fast-dissolving insert combining Griffithsin and Carrageenan for potential use against sexually transmitted infections

Development of a vaginal fast-dissolving insert combining Griffithsin and Carrageenan for potential use against sexually transmitted infections 11 June 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV HPV Product Type(s): Other or N/A Topic(s): MPTs Product Development

Lal et al. Visit Journal Article June 2018
A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use

A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use

A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use 01 June 2018 click to view Journal Article In this Journal Article: Health Risk(s): Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) Topic(s): Product Trials Region(s): Africa

Kestelyn et al. Visit Journal Article June 2018
Contraceptive method use and chlamydia positivity among California Family Planning Clients: The case for new multipurpose prevention technologies

Contraceptive method use and chlamydia positivity among California Family Planning Clients: The case for new multipurpose prevention technologies

Contraceptive method use and chlamydia positivity among California Family Planning Clients: The case for new multipurpose prevention technologies 01 June 2018 click to view Journal Article In this Journal Article: Health Risk(s): Chlamydia Product Type(s): Hormonal Contraceptives Topic(s): Reproductive Health Region(s): United States

Hunter, L.A., Nelson, L., Chow, J.M., Young Holt, B., & Bauer, H.M. Visit Journal Article June 2018
Rapid measures of user’s adherence to vaginal drug products using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and multivariate discriminant techniques

Rapid measures of user’s adherence to vaginal drug products using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and multivariate discriminant techniques

Rapid measures of user’s adherence to vaginal drug products using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and multivariate discriminant techniques 25 May 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) Topic(s): Product Trials

Adedipe et al. Visit Journal Article May 2018
User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences

User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences

User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences 14 May 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) Topic(s): MPTs Product Development Product Introduction / Uptake

Guthrie et al. Visit Journal Article May 2018
Innovative 3D printed intravaginal rings for contraception and HIV prevention

Innovative 3D printed intravaginal rings for contraception and HIV prevention

Innovative 3D printed intravaginal rings for contraception and HIV prevention 10 May 2018 click to view Journal Article In this Journal Article: Health Risk(s): HIV Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) Topic(s): MPTs Product Development

Benhabbour, R., Janusziewicz, R., Mecham, S., Shrivastava, R., & Paravyan, G. Visit Journal Article May 2018
Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model

Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model

Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model April 2018 click to view Journal Article In this Journal Article: Health Risk(s): STI / STD Unintended Pregnancy Topic(s): MPTs Product Development

Young et al. Visit Journal Article April 2018